In March 2025, The Lancet Respiratory Medicine published a phase 2 clinical study article on China's first DPP-1 inhibitor, HSK31858, led by Academician Nan-shan Zhong and Professor Wei-jie Guan from ...
PicoNext AI Assistant claims to be the first generative AI product to summarise raw product data into streamlined, user-friendly DPPs, allowing companies to dramatically reduce time and cost in ...
Bronchiectasis is one of the most common highly heterogeneous chronic inflammatory airway diseases in China. It has a long course, heavy symptom burden, and is prone to recurrent acute exacerbations, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results